| 000 | 01387 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250514232036.0 | ||
| 264 | 0 | _c20060505 | |
| 008 | 200605s 0 0 eng d | ||
| 022 | _a1471-2334 | ||
| 024 | 7 |
_a10.1186/1471-2334-5-49 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNkemngu, Njinkeng J | |
| 245 | 0 | 0 |
_aTreatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon. _h[electronic resource] |
| 260 |
_bBMC infectious diseases _cJun 2005 |
||
| 300 |
_a49 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCameroon |
| 650 | 0 | 4 |
_aCeftriaxone _xtherapeutic use |
| 650 | 0 | 4 |
_aCiprofloxacin _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Multiple, Bacterial |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aNalidixic Acid _xpharmacology |
| 650 | 0 | 4 |
_aSalmonella typhi _xdrug effects |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 |
_aTyphoid Fever _xdrug therapy |
| 700 | 1 | _aAsonganyi, Etienne D N | |
| 700 | 1 | _aNjunda, Anna L | |
| 773 | 0 |
_tBMC infectious diseases _gvol. 5 _gp. 49 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2334-5-49 _zAvailable from publisher's website |
| 999 |
_c15628062 _d15628062 |
||